Upper and Lower Extremity Exercise and Exercise-Induced Hypoalgesia in Knee Osteoarthritis
University of Texas, El Paso · NCT06105788
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 45–90 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 60
- US sites recruiting
- 1
- Study start
- November 15, 2023
- Record last updated
- December 16, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The objective of the study is to explore the effects of arm exercise (UE, arm ergometer) vs. leg exercise (LE, cycling ergometer) on exercise-induced hypoalgesia (EIH), central pain mechanisms and knee pain in people with knee osteoarthritis (OA). Furthermore, we will explore relations of socioeconomic status, racial discrimination, acculturative stress, and autonomic function to exercise effects on EIH, central pain mechanisms, and knee pain. This will be a pilot randomized cross-over study where all participants undergo Day 1 (baseline assessments), Day 2 (UE or LE), and Day 3 (UE or LE).
Being studied: Exercise
Conditions: Knee Osteoarthritis; Knee Pain Chronic; Central Pain Syndrome
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Participants with knee OA (Target n=40)
Inclusion Criteria
We will recruit participants with knee OA, using the National Institute for Health and Care Excellence's clinical diagnostic criteria, which does not require radiographs. The clinical diagnostic criteria include:
- age ≥45
- activity-related knee pain
- either no morning joint-related stiffness or stiffness that lasts ≤ 30 minutes.
- knee pain at least 4 on a 0-10 pain scale
- knee pain as a chief complaint if having multiple pain
- understand English
Exclusion Criteria
- peripheral neuropathy or other sensation loss on the body sites for pain measurements (i.e., the wrist, knee, the forearm)
- use of medical devices electrically active (e.g., pacemaker)
- chronic use of opioids
- pregnant women
- serious and uncontrolled concomitant disease, including cardiovascular, nervous system, pulmonary, renal, hepatic, metabolic, hormonal, endocrine, gastrointestinal or epileptic disease
- rheumatoid arthritis, ankylosing spondylitis, and any neurological disorders that prevent the study procedure
- cognitive impairment
- history of a knee replacement surgery
- inability to perform exercise due to severe pain or other symptoms
- any intervention procedures for knee pain in the last 3 months
Inclusion and exclusion criteria for pain-free controls (Target n = 20) Pain-free controls are not having a pain-related medical condition. They have to speak and understand English. Pain-free controls are excluded if they had experienced a pain episode, caused by musculoskeletal injury or otherwise in the previous 3 months.
Recruiting US locations
The University of Texas at El Paso
El Paso, TX 79968
Site contact: Kosaku Aoyagi, PhD · 915-747-8215 · kaoyagi@utep.edu
Study contacts (from the official record)
- Kosaku Aoyagi, PhD · 9157478215 · kaoyagi@utep.edu
Similar studies in Texas
All arthritis studies in Texas →- RecruitingPhase 2
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Merck Sharp & Dohme LLC
- Location
- Arlington, TX + 35 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Medipost, Inc.
- Location
- Dallas, TX + 33 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or…
AbbVie
- Location
- Houston, TX + 11 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With…
Amgen
- Location
- Bellaire, TX + 73 other US sites
- Eligibility basics
- Ages 18+